Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.
Nicolien T van RavesteynClyde B SchechterJohn M HamptonOguzhan AlagozJeroen J van den BroekKarla KerlikowskeJeanne S MandelblattDiana L MigliorettiBrian L SpragueNatasha K StoutHarry de KoningAmy Trentham-DietzAnna N A Tostesonnull nullPublished in: Journal of the National Cancer Institute (2022)
Triennial screening from age 50 to 74 years may be a reasonable screening strategy for women with lower-than-average breast cancer risk and fatty or scattered fibroglandular breast density.